RUA Life Sciences plc (AIM:RUA)
London · Delayed Price · Currency is GBP · Price in GBX 26.75
+0.25 (0.94%)
Aug 17, 2026, 9:17 AM GMT
RUA Life Sciences Market Cap
RUA Life Sciences has a market cap or net worth of 16.45 million as of August 17, 2026. Its market cap has increased by 118.56% in one year.
Market Cap
16.45M
Enterprise Value
14.77M
Revenue
4.62M
Ranking
n/a
PE Ratio
58.40
Stock Price
26.75
ChartMarket Cap Chart
Since February 26, 1997, RUA Life Sciences's market cap has decreased from 23.82M to 16.45M, a decrease of -30.96%. That is a compound annual growth rate of -1.25%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 17, 2026 | 16.45M | 89.29% |
| Dec 31, 2025 | 8.69M | 27.27% |
| Dec 31, 2024 | 6.83M | 11.68% |
| Dec 29, 2023 | 6.11M | -43.19% |
| Dec 30, 2022 | 10.76M | -35.33% |
| Dec 31, 2021 | 16.64M | -50.66% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 177.75B |
| GSK plc | 72.83B |
| Haleon | 31.32B |
| Smith & Nephew | 9.22B |
| genedrive | 19.27M |
| Renalytix | 17.92M |
| Inspiration Healthcare Group | 16.59M |
| IXICO | 16.35M |